Qingda Granule Attenuates Hypertension-Induced Cardiac Damage via Regulating Renin-Angiotensin System Pathway-Reference-Cited by-同舟云学术

Qingda Granule Attenuates Hypertension-Induced Cardiac Damage via Regulating Renin-Angiotensin System Pathway

Published:2024-09-07 Issue: Volume: Page:
ISSN:1672-0415
Container-title:Chinese Journal of Integrative Medicine
language:en
Short-container-title:Chin. J. Integr. Med.

Author:

Long Lin-zi,Tan Ling,Xu Feng-qin,Yang Wen-wen,Li Hong-zheng,Liu Jian-gang,Wang Ke,Zhao Zhi-ru,Wang Yue-qi,Wang Chao-ju,Wen Yi-chao,Huang Ming-yan,Qu Hua,Fu Chang-geng,Chen Ke-ji

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11655-024-3807-4.pdf

Reference27 articles.

1. Lewington S, Lacey B, Clarke R, Guo Y, Kong XL, Yang L, et al. The burden of hypertension and associated risk for cardiovascular mortality in China. JAMA Intern Med 2016;176:524–532.

2. Forrester SJ, Booz GW, Sigmund CD, Coffman TM, Kawai T, Rizzo V, et al. Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology. Physiol Rev 2018;98:1627–1738.

3. Liu W, Lin S, Cai Q, Zhang L, Shen A, Chen Y, et al. Qingxuan Jiangya Decoction mitigates renal interstitial fibrosis in spontaneously hypertensive rats by regulating transforming growth factor-α 1/Smad signaling pathway. Evid Based Complement Alternat Med 2017;2017:1576328.

4. Long LZ, Chu JF, Qu H, Yang QN, Lu Y, Fu CG, et al. Effects of Qingda Granule on patients with grade 1 hypertension at low-medium risk: study protocol for a randomized, controlled, double-blind clinical trial. Trials 2023;24:1–7.

5. Huang Y, Wu X, Wu M, Chu J, Yu N, Shen A, et al. Antihypertensive and vasodilatory effects of Qingda Granules by suppression of calcium influx and the AKT pathway. J Cardiovasc Pharmacol 2019;74:549–557.